D
Diane L. Fairclough
Researcher at Colorado School of Public Health
Publications - 247
Citations - 19591
Diane L. Fairclough is an academic researcher from Colorado School of Public Health. The author has contributed to research in topics: Randomized controlled trial & Quality of life. The author has an hindex of 76, co-authored 239 publications receiving 18056 citations. Previous affiliations of Diane L. Fairclough include University of Tennessee & Anschutz Medical Campus.
Papers
More filters
Journal ArticleDOI
Recommendations on health-related quality of life research to support labeling and promotional claims in the United States.
Dennis A. Revicki,David Osoba,Diane L. Fairclough,Ivan Barofsky,Rick Berzon,Nancy Kline Leidy,Margaret Rothman +6 more
TL;DR: The scientific practices that should be considered in the evaluation of evidence for an HRQL claim, including the selection of appropriate domains, evidence to support the reliability and validity of HRQL measurement, considerations in research design and statistical analyses, and the issue of clinical significance are outlined.
BookDOI
Design and Analysis of Quality of Life Studies in Clinical Trials
TL;DR: In this article, the authors proposed a model for missing data in health-related quality of life (HRQoL) assessment using a multivariate regression model with multivariate procedures for non-monotone missing data.
Journal ArticleDOI
Understanding Economic and Other Burdens of Terminal Illness: The Experience of Patients and Their Caregivers
TL;DR: To determine the cause of economic and other burdens and to identify some potential interventions that could mitigate them, the authors studied the experiences of 988 terminally ill patients with different illnesses and their 893 caregivers.
Journal ArticleDOI
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness a randomized clinical trial
Jean S. Kutner,Patrick J. Blatchford,Donald H. Taylor,Christine S. Ritchie,Christine S. Ritchie,Janet Bull,Diane L. Fairclough,Laura C. Hanson,Thomas W. LeBlanc,Greg Samsa,Steven Wolf,Noreen M. Aziz,David C. Currow,Betty Ferrell,Nina D. Wagner-Johnston,S. Yousuf Zafar,James F. Cleary,Sandesh Dev,Patricia S. Goode,Patricia S. Goode,Arif H. Kamal,Cordt T. Kassner,Elizabeth Kvale,Elizabeth Kvale,Janelle G. McCallum,Adeboye Ogunseitan,Steven Z. Pantilat,Russell K. Portenoy,Maryjo Prince-Paul,Jeff A. Sloan,Keith M. Swetz,Charles F. von Gunten,Amy P. Abernethy +32 more
TL;DR: It is suggested that stopping statin medication therapy is safe and may be associated with benefits including improved QOL, use of fewer nonstatin medications, and a corresponding reduction in medication costs.
Journal ArticleDOI
Euthanasia and physician-assisted suicide: attitudes and experiences of oncology patients, oncologists, and the public
TL;DR: Euthanasia and physician-assisted suicide are important issues in the care of terminally ill patients and while oncology patients experiencing pain are unlikely to desire these interventions patients with depression are more likely to request assistance in committing suicide.